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ABSTRACT
Yeast Dna2 helicase/nuclease is essential for DNA
replication and assists FEN1 nuclease in processing
a subset of Okazaki fragments that have long single-
stranded 50 flaps. It is also involved in the main-
tenance of telomeres. DNA2 is a gene conserved in
eukaryotes, and a putative human ortholog of yeast
DNA2 (ScDNA2) has been identified. Little is known
about the role of human DNA2 (hDNA2), although
complementation experiments have shown that it
can function in yeast to replace ScDNA2. We have
now characterized the biochemical properties of
hDna2. Recombinant hDna2 has single-stranded
DNA-dependent ATPase and DNA helicase activity.
It also has 50–30 nuclease activity with preference for
single-stranded 50 flaps adjacent to a duplex DNA
region. The nuclease activity is stimulated by RPA
and suppressed by steric hindrance at the 50 end.
Moreover, hDna2 shows strong 30–50 nuclease
activity. This activity cleaves single-stranded DNA
in a fork structure and, like the 50–30 activity, is
suppressed by steric hindrance at the 30-end, sug-
gesting that the 30–50 nuclease requires a 30 single-
ingle-stranded end for activation. These biochemical
specificities are very similar to those of the ScDna2
protein, but suggest that the 30–50 nuclease activity
may be more important than previously thought.
INTRODUCTION
Dna2 is a multifunctional enzyme, conserved in eukaryotes,
and involved in various aspects of DNA metabolism.
Saccharomyces cerevisiae DNA2 (ScDNA2) is essential, and
involved in DNA replication, DNA repair, telomere biogenesis
and stable maintenance of ribosomal DNA (1–7). The function
of ScDna2 in DNA replication has been especially well
studied. ScDNA2 interacts genetically and physically with
proteins involved in lagging-strand DNA synthesis, such as
flap endonuclease (FEN1) and Exo1, and RNaseH2 (1,8–11).
The dna2-1 mutant is temperature sensitive and cannot
synthesize high molecular weight DNA at restrictive temper-
atures (5). Several lines of biochemical evidence indicate that
ScDna2 is involved in primer removal during Okazaki
fragment maturation in cooperation with FEN1 and RPA.
ScDna2 possesses 50–30 helicase activity specific for a forked
substrate, single-stranded DNA-dependent ATPase, and 50–30
exo-endonuclease activity specific to single-stranded DNA
(5,6,12). The nuclease activity of ScDna2 prefers the 50 tail
of flap structure such as might be produced as a result of primer
displacement during Okazaki fragment maturation. Binding of
RPA to flap substrates with a long tail inhibits the nuclease
activity of FEN1, but stimulates the helicase/nuclease activity
of ScDna2, and maturation of the lagging-strand needs both
FEN1 and Dna2 (13–17). It has been proposed that ScDna2
processes an RPA-coated, long flap structure that is a poor
substrate for cleavage by FEN1, resulting in short flaps that are
optimum substrates for FEN1. In the process of flap removal,
Dna2 employs a tracking mechanism that requires the recog-
nition of the free 50-terminus and then movement to the base of
the flap for cleavage (18). Moreover, ScDna2 has a role in the
pathway for the processing of structured flaps, in which it aids
FEN1 using both its nuclease and helicase activities (13,16).
The nuclease activity of ScDna2 is suppressed in the presence
of ATP, allowing the helicase to unwind double-stranded
DNA before the action of nuclease (5–7,12,13). This coupling
of the 50–30 endonuclease activity and DNA helicase activity is
thought to contribute to processing of structured flaps.
Consistent with the role of Dna2 in flap processing, reduced
strand displacement reduces the need for DNA2, while
increased strand displacement and decreased ability to idle
at a nick, increases the need for DNA2 in vivo (8).
In addition to its well-studied role in Okazaki fragment
processing, ScDna2 is involved in both telomerase-dependent
and telomerase-independent telomere elongation pathways
(3). The lethality of deleting the essential Dna2 helicase/
nuclease from budding yeast is suppressed by deletion of
PIF1, which encodes a DNA helicase involved in the sup-
pression of telomere elongation (19–22). In accordance
with its function in telomere maintenance and DNA replica-
tion, ScDna2 is localized to telomeres in G1 and G2 phase of
the cell cycle, but relocalizes during S phase to internal sites in
the chromosomes (3). With respect to ribosomal DNA, a mut-
ant of ScDNA2 shows increased pausing at the rDNA replica-
tion fork barrier (RFB) and accumulates DSBs at the RFB in a
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FOB1-dependent manner. Thus, ScDNA2 is involved in the
maintenance of rDNA (23,24).
DNA2 orthologs are found in all other eukaryotes examined
to date. Consistent with its role in S.cerevisiae DNA replica-
tion, in Schizosaccharomyces pombe, dna2+ is essential,
genetically interacts with lagging-strand processing enzymes
including FEN1 and DNA polymerase d, and is involved in
Okazaki fragment elongation/maturation (25). It also localizes
to telomeres and is involved in telomere metabolism (26). In
metazoans, Caenorhabditis elegans Dna2 protein (CeDna2) is
a helicase/nuclease that can be stimulated by C.elegans RPA,
and homologous deletion of CeDNA2 shows growth defi-
ciency in a temperature-sensitive manner (27,28). CeDNA2
mutants show 90% embryonic viability in F1 but are embry-
onic lethal in F2, a phenotype of telomere deficiency in other
organisms. Xenopus Dna2 is a nuclease/ATPase, and import-
ant for DNA replication in the cell-free DNA replication
system of Xenopus egg extracts, and the XDNA2 gene
complements yeast dna2-1 mutants (29).
These reports suggest that functions of ScDNA2 are
conserved in eukaryotes. However, little is known about the
function of human DNA2 (hDNA2). We have shown that a
putative human DNA2 ORF, DNAL, can complement the
dna2-1 temperature-sensitive mutant of ScDNA2, suggesting
that hDNA2 is a functional ortholog of ScDNA2 (30). Although
mutations in hDNA2 have not yet been directly associated with
human disease, it is notable that the human WRN and BLM
genes, which encode RecQ helicases, can suppress the
lethality of yeast dna2-1 mutations (30,31). This suggests
that Dna2 may functionally interact with or play redundant
roles with these helicases in maintaining telomeres and/or in
suppressing excessive sister chromatid exchange, and that it
is therefore important to investigate the human Dna2 protein
and gene (32).
In this paper, we purified recombinant hDna2 protein
(hDna2) from insect cells, and investigated its biochemical
activity to learn the function of hDna2. hDna2 showed
ATPase/helicase activity and 50–30 exo-endonuclease as
well as 30–50 exo-endonuclease activity, indicating that its
biochemical properties are very similar to those of other
organisms.
MATERIALS AND METHODS
Proteins
hRPA. hRPA and details for its use were from Marc Wold
(University of Iowa, Iowa City, Iowa).
hDna2. To produce recombinant hDna2, hDna2-Flag was
excised from pRS316/GAL-hDNA2-Flag (30) with BamHI/
XhoI and inserted into the corresponding sites of pFastBac
HTc vector (Invitrogen). The nuclease-defective
hDna2D294A point mutant was created using the QuikChange
site-directed mutagenesis kit (STRATAGENE) using the
primers 50-GGATTGAAAGGCAAAATAGCTGTTACAG-
TTGGTGTGAAAATAC-30 and 50-GTATTTTCACACCA-
ACTGTAACAGCTATTTTGCCTTTCAATCC-30 and con-
firmed by DNA sequencing. The helicase-defective
hDna2K671E point mutation was created using the primers
50-GGTATGCCTGGGACAGGAGAAACAACTACGATAT-
GTACTCTC-30 and 50-GAGAGTACATATCGTAGTTGT-
TTCTCCTGTCCCAGGCATACC-30 and was confirmed by
DNA sequencing.
Baculovirus expressing hDna2 (wild type, D294A or
K671E) was infected into High5 cells, and incubated using
shaker flasks for 60 h at 27C (MOI: 5, one liter culture).
Infected cells were then harvested, and resuspended in
100–250 ml lysis buffer [50 mM Tris–HCl, pH 7.5, 150
mM NaCl, 5 mM EDTA, 20% glycerol, 0.1 mM phenyl-
methlysulfonyl fluoride (PMSF) and COMPLETE protease
inhibitor cocktail (Roche)]. Cells (13 g) were lysed by
sonication using BRANSON SONIFIER S-450A with micro-
tip (Duty Cycle 35, Output 6, 10 s, three times), and cell lysates
were clarified by centrifugation for 20 min at 10 000 g. The
supernatant was then incubated with 1 ml of anti-FLAG M2
Affinity Gel (Sigma A2220) equilibrated with lysis buffer
for 1.5–2 h at 4C. After thorough washing with lysis buffer
(100 column volumes), hDna2 was eluted with seven column
volumes of TBS (50 mM Tris–HCl, pH 7.5, 150 mM NaCl)
containing 100 mg/ml of FLAG peptide (Sigma). The amounts
of protein recovered varied in each preparation. The hDna2-
containing fractions were then loaded onto a 1 ml FPLC
MonoQ column equilibrated with MonoQ buffer [150 mM
NaCl, 25 mM Tris–HCl, pH 7.5, 1 mM EDTA, 10% glycerol
(v/v), and 0.1 mM PMSF]. After washing, hDna2 was eluted
with a 10 ml gradient of 100–600 mM NaCl in MonoQ buffer.
hDna2 was eluted at salt concentrations of 300–350 mM.
hDna2-containing fractions were then dialyzed against stock
solution [500 mM NaCl, 25 mM Tris–HCl, pH 7.5, 1 mM
EDTA, 25% glycerol (v/v), 1 mM DTT, 0.15 mg/ml Leupeptin
and 0.1 mM PMSF] and stored at 80C. Dna2 activity was
identified at each purification step by nuclease assay (wild-
type and K671E mutant) or ATPase assay (D294A mutant).
If necessary, enzymes are further diluted to appropriate con-
centrations just prior to use in buffer containing 500 mM
NaCl, 50 mM Tris–HCl, pH 8.0, 2 mM DTT, 0.5 mg/ml
BSA, 10% glycerol (v/v) and 0.02% NP-40.
ATPase assay
Purified hDna2 was incubated in 20 ml of reaction buffer
containing 40 mM Tris–HCl, pH 7.5, 5 mM MgCl2, 25 mM
NaCl, 2.5 mM DTT, 0.1 mg/ml BSA, 5% glycerol (v/v), 1 mg
of oligonucleotide (primer, 22 bases) and various concentra-
tions of [g-32P]ATP at 37C. These conditions were determ-
ined as optimal in separate titrations of ATP, NaCl and time.
The reaction was stopped by adding EDTA to a final con-
centration of 4 mM, and the reaction mix (0.5 ml) was spotted
onto a polyethyleneimine cellulose plate (SELECTO SCI-
ENTIFIC), which was then developed in 0.5 M LiCl, 1 M
formic acid solution. The results were analyzed using the
STORM PhosphoImager.
Nuclease assay
In general, nuclease activities of hDna2 were measured using
a standard reaction mixture (20 ml) containing 50 mM
Tris–HCl, pH 7.5, 25 mM NaCl, 2 mM DTT, 0.25 mg/ml
BSA, the 50- or 30-32P-labeled DNA substrate, and various
concentrations of MgCl2 and ATP as indicated in the figure
legends. NaCl inhibited the nuclease activity (20 times
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inhibition at 125 mM) but 25 mM NaCl was minimally inhib-
itory and included in the reactions to stabilize the oligonuc-
leotide substrates. After incubation at 37C for 15 min,
reactions were stopped with 2· denaturing termination dye
(95% deionized formamide, 10 mM EDTA, 0.1% bro-
mophenol blue and 0.1% xylene cyanol), and boiled for
5 min. The cleavage products were separated on a 12%
sequencing gel (SequaGel, National Diagnostics) using
Model S2 electrophoresis apparatus (BRL, 39 cm plate) and
analyzed using the PhosphoImager. Products were quantified
using the ImageQuant software on the phosphorimager,
Substrate cleaved (%) is calculated as follows: Substrate
cleaved (%) ¼ (product bands)/(substrate bands + product
bands) · 100.
Helicase assay
Helicase assays were performed with the nuclease-deficient
mutant of hDna2 (D294A). The standard reaction mixtures
contained 50 mM Tris–HCl, pH 7.5, 25 mM NaCl, 2 mM
DTT, 0.25 mg/ml BSA, 4 mM MgCl2, 4 mM ATP and
32P-
labeled helicase substrate. After incubation at 37C for 1 h,
reactions were stopped with 5· stop solution (60 mM EDTA,
40% sucrose, 0.6% SDS, 0.25% bromophenol blue and 0.25%
xylene cyanole FF). Reaction products were then separated
using 8% native polyacrylamide gels containing 0.1% SDS,
and detected with PhosphoImager.
hDna2 nuclease substrates
All oligonucleotides were synthesized by Integrated DNA
Technologies (Coralville, IA). Oligonucleotide sequences
are listed in Table 1. The locations of biotinylation are
indicated as underlined nucleotides in the table. The 50 and
30 end labeling of oligonucleotides were performed as
described previously (33). Oligonucleotides were annealed
as described in the figure legends to form various structures.
Flap substrate for the 50–30 nuclease assay were made by
annealing a downstream oligonucleotide, template, and
upstream oligonucleotide at molar ratio of 1:2:4. The upstream
oligonucleotide was omitted to make the forked substrate.
Flap substrates for 30–50 nuclease assays were made by
annealing a downstream, template, and upstream oligonuc-
leotide at molar ratio of 2:1:2 (Figure 5B and C). To check
the specificity of 30–50 nuclease, flap substrates were made by
annealing a downstream template, and upstream oligonuc-
leotide at molar ratio of 4:1:4 (Figure 5A). Upstream
oligonucleotides were omitted to make forked substrate.
Both upstream and downstream oligonucleotide were omitted
to make single-stranded DNA substrate. For annealing, oligo-
nucleotides were placed in TE (1 mM EDTA and 10 mM
Tris–HCl, pH 8.0), heated to 100C for 5 min, and slowly
cooled to room temperature.
hDna2 helicase substrates
The substrate for helicase assay is a 42 base oligonucleotide
(HPR) annealed to M13 DNA over 24 bases and having an
18 nt 50 noncomplementary tail (for sequence see Table 1).
The oligonucleotide was 50 radiolabeled with [g-32P]ATP
by T4 polynucleotide kinase in accordance with the manufac-
turers instructions, annealed to M13 single-stranded DNA
(NEB), and purified with a Sepharose CL4B column (Sigma).
Production of anti-human Dna2 antibodies
The plasmid pBS-SK-hDNA2 that contained cDNA encoding
hDNA2 (accession no. KIAA0083, KAZUSA DNA Res. Inst.)
was used to amplify the N-terminal DNA fragment encoding
amino acids 18–353 of hDna2 and a 6· HIS tag at the
C-terminus using the primers 50-GTCCCATATGGAG-
CAGCTGAACGAAC-30 and 50-CAGTCTCGAGGTAGA-
GAAGCAAGCC-30. The amplified fragments were digested
with NdeI and XhoI, and cloned into pET-24a(+) vector
(Novagen) cleaved with the same restriction enzymes to gen-
erate pET-24a(+)-hDna2-NT-HIS. Protein expression and
purification was performed by C&P Biotech Corp. (Ontario,
Canada). In brief, the protein was expressed in five liters of
Escherichia coli BL21 (DE3) cells using 0.5 mM Isopropyl-b-
D-thiogalactopyranoside at 37C for 3 h. Cell pellet was
harvested, resuspended with lysis buffer (50 mM Tris–HCl,
pH 8.0, 500 mM NaCl, 1 mM PMSF, 1 mM benzamidine,
1 mg/ml of Leupeptin and aprotinin), and disrupted with son-
ication. Since most of the hDna2-NT-HIS protein was found in
inclusion bodies, hDna2-NT-HIS was then solubilized with
8 M urea and 10 mM DTT, and purified with a HisTrap
(Pharmacia) column according to manufacturers instructions.
Eluted samples were then dialyzed into 50 mM Tris–HCl,
pH 8.0, 50 mM NaCl, 4 M urea and 1 mM DTT, loaded
onto QFF ion-exchange column, and eluted with 0–500 mM
NaCl gradient. Fractions from QFF columns were combined,
concentrated, and purified further with S200 size exclusion
column using 50 mM Tris–HCl, pH 8.0, 50 mM NaCl, 2 M
urea and 1 mM DTT.
Anti-Dna2 antibodies were produced against the purified
hDna2-NT-HIS protein in rabbits at COVANCE (Denver,
Table 1. Oligonucleotide sequence (50–30)
Downstream
D(55mer) AGGTCTCGACTAACTCTAGTCGTTGTTCCACCCGTCCACCCGACGCCACCTCCTG
D-bio(55mer) AGGTCTCGACTAACTCTAGTCGTTGTTCCACCCGTCCACCCGACGCCACCTCCTG
Template
T (51mer) GCAGGAGGTGGCGTCGGGTGGACGGGATTGAAATTTAGGCTGGCACGGTCG
T-bio (50mer) GCAGGAGGTGGCGTCGGGTGGACGGGATTGAAATTTAGGCTGGCACGGTC
Upstream
U (26mer) CGACCGTGCCAGCCTAAATTTCAATA
Helicase
HPR (42mer) AGCTAGCTCTTGATCGTAGACGTTGTAAAACGACGGCCAGTG
The underlined nucleotides indicate a biotin modification.
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PA). Anti-Dna2 antibodies were purified by affinity chroma-
tography (34) on Affigel 15 (BioRad) containing covalently
bound hDna2-NT-HIS. Control IgG was purified from pre-
immune serum using protein A beads (Amersham).
Immunoprecipitation of hDna2 proteins
HeLa cell nuclear extracts were the gift of Carl Parker
(California Institute of Technology, Pasadena, CA). 20 ml
of protein A beads (Amersham) was incubated with 10 ml
of anti-Dna2 serum or control serum for 30 min at 4C,
and then washed with IP buffer (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, 2 mM EDTA, 10% glycerol, 1 mM PMSF,
15 mM DTT and 0.2% NP-40). HeLa nuclear extract (25 ml)
or recombinant hDna2 (1.2 mg) was then incubated with
beads from above for 1 h at 4C. After incubation, the
beads were washed with IP buffer, and immunoprecipitates
were analyzed by western blotting. The supernatants (10 ml)
of the immunoprecipitation were also assayed.
Preparation of experimental data as computer images
Images were edited using the levels command of Adobe
Photoshop. Specifically, images were enhanced by dragging
Figure 2. ATPase activity of recombinant hDna2 proteins. (A) DNA-dependent
ATPase activity of human DNA2. ATPase activity of recombinant hDna2
wild type (WT), D294A (DA) or K671E (KE) were measured using reaction
mixtures containing [g-32P]ATP in the presence (+) and absence () of
single-stranded DNA as described in Materials And Methods. Reactions
contained 600 fmol of recombinant protein and 0.5 mM [g-32P]ATP. After
incubation for 20 min at 37C, the reaction products were separated by thin
layer chromatography and detected using PhosphoImager. ATP indicates
the position of uncleaved ATP. Pi indicates position of released inorganic
phosphate. As a control, protein was omitted from the reaction (Buffer).
(B) Extent of ATPase. The ATPase activity of wild-type hDna2 was measured
using reaction mixtures containing various concentrations of [g-32P]ATP,
and extents of ATP hydrolysis were plotted against ATP concentration. To
normalize background, ATPase activity was measured in the absence of
single-stranded DNA and subtracted.
Figure 1. Production of recombinant hDna2 proteins. (A) Schematic diagram
of the recombinant human Dna2 proteins. Positions of hDna2 point mutations at
conserved amino acids of the nuclease domain (D294A) and the helicase
domain (K671E) are shown. (B) Purified recombinant hDna2 proteins.
Recombinant hDna2 wild type (WT), nuclease negative (DA) and ATPase
negative (KE) were subjected to SDS–PAGE and stained with Coomassie
staining (CBB) or detected with anti-Flag antibodies (Anti-FLAG). Molecular
weight markers are shown on the left. (C) Detection of hDna2 in human cells.
Purified hDna2 (Recombinant) or HeLa nuclear extract (HeLa) were separated
by SDS–PAGE, and detected with western blotting using either affinity purified
polyclonal antibody against N-terminal amino acids of hDna2 (ahDna2 IgG)
or control antibodies (Control IgG). Positions of hDna2 are indicated by
arrowhead. (D) Immunoprecipitation of hDna2. Recombinant hDna2 (lanes
1–5) or HeLa nuclear extract (lanes 6–10) were immunoprecipitated with pre-
immune serum (Pre) or anti-hDna2 (ahDna2) antibodies, and detected with
western blotting using anti-hDna2-NT antibodies. Lanes 1 and 6, input; lanes 4,
5, 9 and 10, immunoprecipitates; lanes 2, 3, 7 and 8, supernatant of the
immunoprecipitation.
1868 Nucleic Acids Research, 2006, Vol. 34, No. 6
the black and white input levels sliders to the edge of the first
group of pixels on either end of the histogram.
RESULTS
Preparation of recombinant human Dna2 protein from
baculovirus-infected insect cells
Previously, we have shown that DNA2L, cDNA accession
number KIAA0083 (Swiss prot accession no. P51530,
Genbank accession no. D42046), can complement the yeast
dna2-1 mutant (30). This result strongly suggests that DNA2L
is the human ortholog of ScDNA2, although the enzymatic
properties of hDna2 protein have not been investigated. To
learn if the hDna2 has similar biochemical activity to that of
ScDna2, we purified recombinant hDna2. The human DNA2
gene was tagged at the N-terminus with six histidines and at
the C-terminus with a FLAG tag, cloned into a baculovirus
expression vector, expressed in High5 insect cells, and purified
as described under Materials And Methods. To prepare
Figure 3. Helicase activity of recombinant hDna2 proteins. (A) Effect of D294A mutation on the 50–30 nuclease activity of hDna2. The 50–30 nuclease activity of
hDna2 was measured as described in Materials And Methods. Reaction mixtures contained either hDna2 wild type (WT) or D294A mutant (DA) (300 fmol). As a
negative control, enzyme was omitted from the reaction (Sub). The flap (D:T:U) substrate used (15 fmol) is shown at the top of the figure (star, 32P-labeled ends).
Numbers shown on the left of the figure indicate the size of the markers. Proteins were preincubated with substrates before adding Mg++ to a final concentration of
0.5 mM, and then further incubated for 10 min at 37C. (B) Helicase activity of recombinant hDna2. The 50 end-labeled oligonucleotide annealed with M13
single-stranded DNA (star, 32P-labeled end) was incubated with hDna2D294A in the presence of ATP (+ATP), or ATP-g-S (ATP-g-S) as indicated. As a control, ATP
was omitted from the reaction (ATP). Reactions were stopped at indicated times by adding 5· stop solution. Products were then separated using native gel
electrophoresis and detected by autoradiography. Boil denotes boiled substrate to indicate the position of the unwound strand. As a control, hDna2 was omitted from
the reaction mixture (Buffer). Positions of substrate (Substrate), helicase products (Unwound product) and nuclease products (Cleaved products) are as indicated on
the left.
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nuclease-deficient and ATPase-deficient mutant enzymes,
conserved amino acids in hDna2 corresponding to those
critical for endonuclease and ATPase of budding ScDna2
were changed (Figure 1A) (6,7). Purification of recombinant
hDna2 was confirmed using anti-FLAG antibodies
(Figure 1B, right). Purity of the recombinant proteins was
estimated as >90% on Coomassie-stained gels. Similar levels
of purity were obtained with each of the mutant proteins
(Figure 1B, left).
We then performed western blotting to establish the presence
of endogenous hDna2 in human cells. Recombinant hDna2 or
HeLa nuclear extract were separated by SDS–PAGE, and
hDna2 was detected after blotting using polyclonal antibody
raised against hDna2 N-terminal fragment. Anti-hDna2 anti-
body detected a protein of 120 kDa from both recombinant
hDna2 and human nuclear extract (Figure 1C). Since the
molecular weight of hDna2 expected from its amino acid
sequence is 119 kDa, this result strongly suggests the cDNA
clone encodes full-length hDna2 in human nuclei. The anti-
hDna2 antibody could immunoprecipitate a protein of 120 kDa
both from a solution of recombinant hDna2 and from HeLa
nuclear extracts, further supporting our conclusion that this
band corresponds to hDna2 (Figure 1D).
DNA-dependent helicase and ATPase activities of
recombinant hDna2 proteins
ScDna2 possesses single-stranded DNA-dependent ATPase
activity (5,6). To see if the enzymatic activity of ScDna2 is
conserved in human, we investigated the ATPase and helicase
activity of recombinant hDna2. As shown in Figure 2, wild-
type hDna2 showed ATPase activity, optimized as described
in Materials And Methods. The ATPase activity of hDna2
required single-stranded DNA, indicating a similar cofactor
requirement to that of ScDna2. The ATPase activity of hDna2
proteins were calculated at a time point that gives initial rate of
ATP hydrolysis, and the rate of ATP hydrolysis was 10% of
ScDna2 (Figure 2B, Discussion). The apparent Km for the
ATPase activity was 400 mM. The K671E mutation (KE)
abolishes the ATPase activity, confirming that the Walker
A box is part of the active site of the DNA-dependent ATPase.
On the other hand, a mutation in the nuclease domain (D294A,
DA) had no effect on the ATPase activity (Figure 2).
ScDna2 possesses a distributive helicase activity, and
unwinds a DNA duplex with a 50 tail in an ATP hydrolysis
dependent manner (5,12,13). Therefore, we next investigated
the helicase activity of recombinant hDna2. For this assay, a
mutant hDna2 with a point mutation in a conserved amino acid
in the nuclease domain (hDna2D294A) was used to prevent
degradation of substrate. The D294A mutation abolished most
of the nuclease activity of hDna2, as expected (Figure 3A). As
a substrate for measuring unwinding, we used an oligonuc-
leotide annealed to M13 single-stranded phage DNA, which
yields a forked structure with a noncomplementary 50 tail of 18
nt. This kind of molecule has been shown previously to be a
good substrate for the DNA helicase activity of ScDna2 (5,6).
As shown in Figure 3B, hDna2D294A showed significant
displacement of the labeled oligonucleotide (Figure 3B,
Unwound product). The unwinding is dependent on ATP,
and ATP-g-S will not substitute, indicating that unwinding
is dependent on ATP hydrolysis. We detect some residual
nuclease activity in the absence ATP, but addition of ATP
significantly suppressed this nuclease activity (Figure 3B,
Cleaved products). Since strand displacement is dependent
on ATP hydrolysis and residual nuclease activity is inhibited
by ATP, we conclude that the displaced strand is not a product
of nuclease activity, but a product of helicase activity. These
results indicate that recombinant hDna2 possesses DNA
helicase activity.
Analysis of the 50-nuclease activity of hDna2
It has previously been shown that the 50–30 nuclease activity of
ScDna2 is essential (2,7). ScDna2 cleaves forked or flap sub-
strates adjacent to the duplex region, resulting in products
appropriate for further processing by FEN1 nuclease. The
nuclease activity of ScDna2 is regulated by ATP. Addition
of ATP suppresses the nuclease activity and activates DNA
helicase activity, allowing unwinding of flap substrates and
cleavages beyond flap base (5,7,12,13). To see if these
properties of ScDna2 are conserved in hDna2, we next invest-
igated the spectrum of hDna2 nuclease products in the
presence of various concentrations of ATP. To accomplish
this, we employed flap or forked substrates labeled at either
the 30 or 50 end of the downstream oligonucleotide (Figure 4A
and B). Figure 4A shows that the final products of nuclease
(labeled at the 30 end) are around 25–35 nt long, which means
that hDna2 cleaves the flap or fork up to a few nucleotides
from the base of the flap (lane 2). This cleavage pattern is
similar to that of ScDna2 in the absence of ATP (35). Addition
of ATP reduced the extent of the nuclease activity (lane 3).
Nuclease products with length of <25 nt were not observed,
Figure 4. The 50–30 nuclease activity of recombinant hDna2. (A) Effect of ATP on the 50–30 nuclease activity of hDna2. The 50–30 nuclease activity of hDna2 was
measured in the presence of various concentrations of ATP and Mg++ as described in Materials And Methods. The concentrations of ATP and Mg++ are as shown on
the figure. Reaction mixtures contained either hDna2 wild type (WT, lanes 2–5) or ATPase negative (KE, lanes 6–9) (20 fmol). As a negative control, enzyme was
omitted from the reaction (Sub, lane 1). The flap substrate used (D:T:U, 15 fmol) is shown at the top of the figure. Numbers shown on the left of the figure indicate the
size of the markers. Proteins were preincubated with substrates for 5 min at 4C before adding Mg++. (B) Determination of cutting position of 50–30 nuclease activity of
hDna2. Nuclease assays were performed as described in (A) using 50 (lanes 1–13) or 30 (lanes 14–26) end-labeled forked substrates (D:T) without preincubation.
Reaction mixtures contained either hDna2 wild type (WT, lanes 2–7 and 15–20) or ATPase negative (KE, lanes 8–13 and 21–26). 1 fmol (lanes 2–4, 8–10, 15–17 and
21–23) or 5 fmol (lanes 5–7, 11–13, 18–20 and 24–26) of hDna2 wild type are used as shown in the figure. (C) Effect of RPA on the 50–30 nuclease activity of hDna2.
Time course of 50–30 nuclease activity of hDna2 (30 fmol) on flap substrate (D:T:U, 30 fmol + 30 fmol T + 90 fmol U) was assayed in the presence of increasing
amounts of hRPA (0–600 fmol) as shown in the figure. NaCl (125 mM) was included to suppress destabilization of the substrate by hRPA. Reaction mixtures were
preincubated without hDna2 at 4C for 10 min to allow binding of RPA to the substrates. Percentage substrate cleaved was determined as described in Materials And
Methods. (D) The 50–30 nuclease activity of hDna2 requires a free 50 end. The 50–30 nuclease activity of wild-type hDna2 (20 fmol) was measured using unmodified
[D:T (Sub), lanes 1, 3–4 and 7–11] or 50 biotinylated [(D-bio:T (Sub-bio), lanes 2, 5–6 and 12–16] fork substrates (15 fmol) in the presence of increasing amounts (0,
2.5, 5, 10 and 20 fmol, as indicated by triangles) of streptavidin. Reaction mixtures were preincubated at 4C for 15 min without enzymes to promote formation of
biotin-streptavidin complex. As negative control, unbiotinylated (lanes 3 and 4) or biotinylated (lanes 5 and 6) substrates were incubated in the absence (, lanes 3 and
5) or presence (+, 20 fmol, lanes 4 and 6) of streptavidin without hDna2. Lanes 1 and 2 show substrate only control.
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indicating that cleavage products beyond the flap base were
not produced for hDna2 even in the ATP/Mg++ ratio (1:1),
which allows unwinding of 50-tailed partial duplex DNA
(Figure 3). Surprisingly, the KE mutation that abolishes
ATPase activity did not affect the suppression of nuclease
activity by ATP (Figure 4A, compare WT with KE). This
result may indicate that the change of cleavage position in
the presence of ATP is not dependent on binding of ATP to the
Walker A box, although this mutation has not been shown
directly to abolish ATP binding in Dna2. Nor did the addition
of excess Mg++ over ATP prevent suppression of the nuclease
by ATP (lanes 3, 4, 7 and 8); thus the suppression is not likely
due to titration of Mg++.
We next investigated the nuclease activity using a forked
substrate labeled at the 50 end to investigate sequential cleav-
age from the end of strand (Figure 4B, left). This substrate
produced nuclease products of >5 nt, suggesting that the first
cleavage position by hDna2 is around 5 nt away from the
50 end (lanes 2, 5, 8 and 11). Addition of ATP resulted in
the release of longer nuclease products, again indicating an
inhibition of nuclease by ATP, although the KE mutation did
not affect the inhibition (Figure 4B, lanes 3, 4, 6, 7, 9, 10, 12
and 13). We could not detect cleavage in the duplex DNA
region (>30 nt), however, consistent with the results using
30 end-labeled substrate (Figure 4B, compare lanes 2–7 and
15–20). These results show that cleavage points of flap and
fork substrates by the 50–30 nuclease of hDna2 are very similar
to those of ScDna2, although hDna2 cannot cleave the double-
stranded region beyond the flap base, even in the presence
of ATP.
It has been shown that the enzymatic activities of ScDna2
can be stimulated by yeast RPA, indicating a functional inter-
action between these two proteins (36). To determine if the
interaction is conserved in human proteins, we next assayed
stimulation of hDna2 by human RPA (hRPA). RPA itself
destabilized the duplex DNA substrates at the low salt con-
centrations optimal for Dna2 activities (25 mM and below).
We found that the duplex can be stabilized in the presence of
RPA, however, by the addition of NaCl to the reaction. NaCl
was titrated into reaction mixtures containing RPA to deter-
mine a minimal concentration where the duplex was stable
even in the presence of 4-fold excess of RPA and the nuclease
was still active. This NaCl concentration was found to be 125
mM. As with yeast Dna2 [(37) and data not shown], 125 mM
inhibited hDna2 about 20-fold (as determined by quantitative
comparison of data from Figure 4A and B with Figure 4C).
Figure 4C shows a time course of nuclease activity in the
presence of increasing amounts of hRPA. Addition of RPA
stimulated the nuclease activity up to 8- to 10-fold, in a dose-
dependent manner. These results indicate that the 50–30 nucle-
ase activity of hDna2 is stimulated by hRPA.
Yeast Dna2 prefers free 50 ends, and conjugation of biotin–
streptavidin at the 50 end can suppress 50–30 nuclease activity
(18). To see if steric hindrance at the 50 end inhibited the 50–30
nuclease activity of hDna2, we next placed a biotin modifica-
tion at the 50 end of the flap substrate and investigated effects
of a biotin–streptavidin complex on nuclease cleavage. As
shown in Figure 4D, cleavage of biotinylated substrate was
inhibited by increasing amounts of streptavidin, although
unmodified forks were cleaved equally well in the absence
or presence of streptavidin (compare lanes 7–11 and 12–16).
This result indicates that the 50–30 nuclease activity of hDna2
requires a free 50 end and that hDna2 may therefore use the
same tracking mechanism as ScDna2.
30–50 Nuclease activity of hDna2
It has been reported that ScDna2 has 30–50 nuclease activity in
addition to 50–30 nuclease (35). To learn more about the sim-
ilarity of yeast and human Dna2, we next investigated the 30–50
nuclease activity of hDna2. We first compared nuclease
products of forked and flap substrates. As shown in
Figure 5A, hDna2 showed 30–50 nuclease activity against
single-stranded DNA and a forked substrate, but not against
a 50-flap substrate with fully duplex 30 ends. This result indic-
ates that hDna2 has 30–50 nuclease activity specific to single-
stranded ends. The length of the nuclease product from a
forked substrate labeled at the 50 end was around 35 nt, indic-
ating that around 10 nt of single-stranded DNA at the fork was
left uncleaved after the reaction (lanes 9–11). This spectrum of
cleavage products differs from that of the 50–30 nuclease,
which can cleave closer to the duplex region (Figure 4).
Like, the 50–30 nuclease, the 30–50 nuclease activity was
suppressed by the D294A mutation, showing that the same
active site is employed for both 50–30 and 30–50 nuclease activ-
ities (Figure 5A, DA).
To see if the 30–50 nuclease activity of hDna2, like the 50–30
activity, also requires free ends, we next placed biotin at the
30 end of the substrate and investigated the effect of strep-
tavidin on the nuclease activity of hDna2. As shown in
Figure 5B, cleavage of biotinylated substrate was inhibited
by increasing amounts of streptavidin, although substrates
lacking biotin were cleaved equally well in the absence or
presence of streptavidin (compare lanes 7–11 with 12–16).
This result indicates that the 30–50 nuclease activity of
hDna2 requires a free 30 end, and may employ a similar track-
ing mechanism to that of the 50–30 nuclease, consistent with
there being a single active site for both nuclease activities.
Finally, we investigated effects of ATP on the 30–50 nucle-
ase activity using various concentrations of ATP and Mg++ as
shown in Figure 5C. In the absence of ATP, the length of
nuclease products was mainly 30–35 nt. In the presence of
ATP, nuclease activity was reduced and released slightly
longer nuclease products (30–40 nt) indicating inhibition of
nuclease (lanes 3 and 4). However, cleavage products below
30 nt were not detected in the presence of ATP, again
indicating that there is no cleavage in the double-stranded
region. This result is consistent with the behavior of the
50–30 nuclease, and indicates that there is no unwinding of
the fork substrate before cleavage.
DISCUSSION
In this paper, we investigated the enzymatic activities of
hDna2 to obtain insights into the function of Dna2 in
human cells. Our results show that hDna2 is a helicase/
nuclease with similar properties to those of Dna2 orthologs
in other organisms, indicating the functional conservation
of DNA2.
ScDna2 possesses a distributive helicase/ATPase activity,
and can unwind DNA duplex with 50-tail (5,6,12,13). Here, we
showed that recombinant hDna2 also has ATPase/helicase
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Figure 5. The 30–50 nuclease activity of hDna2. (A) The 30–50 nuclease activity of hDna2 is specific to single-stranded region. 30–50 nuclease activity of hDna2 was
measured with 15 fmol of single-stranded DNA (T, lanes 1–7), forked substrate (D:T, lanes 8–14), or flap substrate (D:T:U, lanes 15–21) in the presence of increasing
amounts (20, 100 and 600 fmol, as indicated by the triangles) of hDna2 wild type (WT, lanes 2–4, 9–11 and 16–18) or nuclease-defective (DA, lanes 5–7, 12–14 and
19–21). Enzyme was omitted from the reaction as negative control (Sub, lanes 1, 8 and 15). Reaction mixture contained 4 mM Mg++ and no ATP. Proteins were
preincubated with substrate for 5 min at 4C before adding Mg++. (B) The 30 nuclease activity of hDna2 requires a free 30 end. Effect of increasing amounts of
streptavidin (0, 2.5, 5, 10 and 20 fmol, as indicated by triangles) on 30–50 nuclease activity of wild-type hDna2 (20 fmol) was investigated using unmodified [D:T,
(Sub), lanes 1, 3–4 and 7–11] or 30 biotinylated fork [D:T-bio (Sub-bio), lanes 2, 5–6 and 12–16] substrates (15 fmol) as described in Figure 4D. (C) The 30–50 nuclease
activity of hDna2 is inhibited by ATP. The 30-nuclease activity of hDna2 wild type (20 fmol) was measured in the presence of various concentrations of ATP and Mg++
as described in Figure 4A. The forked (D:T, lanes 1–5) and flap (D:T:U, Lanes 6–10) substrates used (15 fmol) are shown at the top of the figure. As a negative control,
enzyme was omitted from the reaction (Sub, lanes 1 and 6).
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activity (Figures 2 and 3). This activity is intrinsic to the
recombinant hDna2, because mutation of the ATPase domain
resulted in the inactivation of ATPase. The rate of ATP hydro-
lysis was quite low, 2.6/s, around 10% of the ATP hydrolysis
rate reported for ScDna2 (Figure 2) (7). Consistent with the
low ATPase activity, the helicase activity of hDna2 is not high.
We needed excess hDna2D294A to detect displacement of
substrate (Figure 3), and cleavages by the nuclease beyond
the flap base, which have been reported for ScDna2, were not
observed for hDna2, even at the ATP/Mg++ ratio that allows
nuclease-defective hDna2 to unwind a 50-tailed, partial duplex
DNA (12,13) (Figures 4 and 5). One possible explanation for
this low ATPase/helicase activity of hDna2 is that substrates
used in this experiment are not the endogenous substrate of
hDna2. For example, ScDna2 shows dynamic localization to
telomeres, and is involved in telomerase-dependent and
telomerase-independent telomere elongation, suggesting that
Dna2 acts on telomere DNA (3). Alternatively, our previous
results using substrates with secondary structure showed that
the helicase activity of ScDna2 is essential for effective
nuclease cleavage of this substrate (16). The helicase activity
of Dna2 may be specialized for processing of these special
sequences.
Previous reports have shown that the nuclease active site of
ScDna2 is required for the viability of budding yeast, and it
was proposed that the function of Dna2 is processing of 50-flap
structures in cooperation with RPA and FEN1 during Okazaki
fragment maturation (2,7,36). We investigated the 50–30 nucle-
ase activity of the hDna2 to see if hDna2 has similar nuclease
activity to that of ScDna2. As shown in Figure 4, the position
of the cutting in the absence of ATP is near the base of the
displaced single strand, indicating a striking similarity of the
nuclease specificity between human and yeast (35). Other
features that suggest similarity between the nuclease activities
of ScDna2 and hDna2 include (i) cleavage position near the
end of strand (Figure 4B) (12), (ii) suppression of nuclease
activity by steric hindrance from biotin–streptavidin conjuga-
tion at 50 end (Figure 4C) (18), (iii) activation of 50–30 nuclease
by hRPA (Figure 4D) (36), and (iv) Inhibition of nuclease by
ATP (5,7,9,14). One difference is apparent lack of coupling
of nuclease and helicase in hDna2. The coupling of nuclease
and helicase may be important when Dna2 processes flap
substrates with secondary structures (16). However, we
could not detect nuclease product cleaved in the double-
stranded region of flap substrates, perhaps because addition
of ATP resulted in the inhibition of nuclease (Figure 4A and
B). The helicase activity of hDna2 may be too weak to allow
the coupling of nuclease and helicase, or a special substrate is
required to show optimum helicase activity (see above).
Regulation of nuclease activity by ATP is interesting, since
it is conserved between yeast and human Dna2. ATP may
titrate Mg++ or may cause a change of Dna2 structure, leading
to the suppression of nuclease.
It has been shown that ScDna2 possesses 30–50 nuclease
activity in addition to 50–30 nuclease (6,35), but the activity
was lower than that of the 50–30 nuclease, and the function of
the nuclease has not been established. In this paper, we
performed detailed analysis of the 30–50 nuclease activity of
hDna2. As shown in Figure 5, hDna2 also showed 30–50
nuclease activity, indicating that this is a conserved activity
of Dna2 orthologs. This activity is specific for a
single-stranded region, is inhibited in the presence of ATP,
and needs a free 30 end of single-stranded DNA for activity.
The requirement for a free 30 end suggests that the 30–50 nucle-
ase employs a similar tracking mechanism to that of the 50–30
nuclease activity (Figures 4D and 5B). The 30–50 nuclease
activity was suppressed by the D294A mutation to the same
extent as the 50–30 nuclease activity, indicating that the same
active site is employed for both nuclease activities. On the
other hand, regulation of these two nuclease activities is not
exactly the same, since hRPA did not stimulate 30–50 nuclease
activity (data not shown), and the spectrum of cleavage
positions is different (compare Figures 4A and 5A). This
kind of dual-polarity nuclease activity has been reported in
E.coli RecB enzyme. As in hDna2, the same active site in
RecB catalyzes both nuclease activities, with the 30–50 activity
differentially inhibited by the presence of the specific chi
sequence (38). There might be a similar switch in Dna2
helicase, though further investigation is required to determine
the role of the 30–50 nuclease. This finding leads to the specu-
lation that Dna2 may function on equilibrating flaps at Okazaki
fragment junctions in conjunction with DNA polymerase d.
Such a model would account for the synthetic lethality of
dna2-1 and pol3-01, a mutant defective in the 30 exonuclease
exonuclease of pol d and may also be related to the suppres-
sion of dna2-1 by pol32D, a mutant that may lead to decreased
strand displacement by pol d (8).
In conclusion, we believe this gene is a functional ortholog
of ScDNA2 for the following reasons. (i) hDna2 shows
conservation throughout the length of the protein coding
sequence, including the nuclease domain (29). (ii) The enzym-
atic properties of hDna2 are strikingly similar to those of
ScDna2. (iii) The hDNA2 gene can complement temperature-
sensitive phenotype of Sc dna2-1 (30). We are now planning
further studies, using the specific antibodies described here, of
the in vivo function of hDna2 in human cells, which will give
us insights into the role of Dna2 in DNA replication, tumori-
genesis, telomere maintenance and aging in human cells.
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